Company Filing History:
Years Active: 2016-2017
Title: Mark G Obukowicz: Innovator in Pain and Inflammation Treatment
Introduction
Mark G Obukowicz is a notable inventor based in Three Lakes, WI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address pain and inflammation. With a total of 3 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Obukowicz's latest patents focus on deuterated benzopyran compounds. These compounds exhibit excellent anti-inflammatory and analgesic effects, as well as the capability to inhibit the growth of tumor cells. His inventions are novel COX-2 selective inhibitors, which can be utilized in the preparation of anti-inflammatory and analgesic drugs, as well as drugs for treating or preventing tumors. The detailed structure features of these compounds are outlined in Formula (I), along with their pharmaceutically acceptable salts or stereoisomers.
Career Highlights
Mark G Obukowicz is affiliated with the Chinese Academy of Sciences, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation in the pharmaceutical industry, particularly in the realm of pain management and cancer treatment.
Collaborations
Obukowicz collaborates with esteemed colleagues such as Yanmei Zhang and John Jeffrey Talley. Their combined expertise contributes to the advancement of research in their field.
Conclusion
Mark G Obukowicz stands out as an influential inventor whose work in developing deuterated benzopyran compounds holds promise for improving treatment options for pain and inflammation. His contributions to the pharmaceutical industry are noteworthy and continue to inspire further research and innovation.